Physician profile
Mark V Graytok
NPI 1952373318
$7,686.41
in general payments reported to CMS, 2019-2025
18 companies · $1,811 in 2025
The $1,811 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $434 · 2021: $927 · 2022: $1,452 · 2023: $1,954 · 2024: $664 · 2025: $1,811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,255 · Travel and Lodging: $1,132 · Entertainment: $42.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,255.13 |
| Travel and Lodging | $1,131.76 |
| Entertainment | $42.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $5,143.44 | 2019-2025 | Air Optix, Dailies Aqua Comfort Plus, Precision7 |
| Lumenis Be INC | $1,006.72 | 2025 | M22 |
| Johnson & Johnson Vision Care, INC. | $564.72 | 2020-2025 | Acuvue |
| Biotissue Holdings INC. | $181.75 | 2019-2024 | |
| Heru, INC. | $174.13 | 2022 | |
| Bausch & Lomb Americas INC. | $97.37 | 2022-2025 | Infuse |
| Coopervision INC. | $82.98 | 2022-2025 | Clariti Contact Lens, Misight Contact Lens |
| Topcon Healthcare, INC. | $75.95 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $50.94 | 2019-2021 | |
| Alcon Research LLC | $48.14 | 2019 | |
| Sun Pharmaceutical Industries INC. | $45.92 | 2023 | Cequa |
| Novartis Pharmaceuticals Corporation | $43.74 | 2020-2021 | |
| Optos, INC. | $42.66 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Allergan, INC. | $37.16 | 2021 | |
| Abb Con-Cise Optical Group LLC | $32.87 | 2019-2025 | Spectacle Lenses |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $23.33 | 2021 | |
| Shire North American Group INC | $19.15 | 2019 | |
| Abbvie INC. | $15.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Graytok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.